Teladoc Health (TDOC) Cost of Revenue (2014 - 2026)

Teladoc Health has disclosed Cost of Revenue across 13 years of filings, most recently posting $190.8 million for Q2 2026.

• In Q2 2026, Cost of Revenue changed 0.16% year-over-year to $190.8 million; the TTM figure through Jun 2026 stood at $772.6 million (up 2.19% YoY), while the FY2025 annual figure was $771.6 million, up 2.71% from the prior year.
• Cost of Revenue came in at $190.8 million for Q2 2026 at Teladoc Health, down from $197.5 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $197.5 million in Q1 2026 to a low of $179.7 million in Q3 2024.
• Average Cost of Revenue over 5 years is $189.7 million, with a median of $189.5 million recorded in 2023.
• Year-over-year, Cost of Revenue advanced 28.14% in 2022 and dropped 3.34% in 2024.
• Over 5 years, Cost of Revenue stood at $188.9 million in 2022, then grew by 2.41% to $193.4 million in 2023, then dropped by 2.32% to $188.9 million in 2024, then gained by 4.3% to $197.0 million in 2025, then dropped by 3.15% to $190.8 million in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $190.8 million in Q2 2026, $197.5 million in Q1 2026, and $197.0 million in Q4 2025.